Anisomycin Induces Glioma Cell Death Via Down-regulation of PP2A Catalytic Subunit in Vitro

Overview

Journal Acta Pharmacol Sin

Specialty Pharmacology

Date 2012 Jun 12

PMID 22684030

Citations 22

Authors

Jun-Yang Li

Jia-Yuan Huang

Meng Li

Han Zhang

Biao Xing

Gong Chen

Dong Wei

Pei-Yuan Gu

Wei-Xing Hu

Affiliations

Soon will be listed here.

Abstract

Aim: To examine the effects of anisomycin on glioma cells and the related mechanisms in vitro.

Methods: The U251 and U87 human glioblastoma cell lines were tested. The growth of the cells was analyzed using a CCK-8 cell viability assay. Apoptosis was detected using a flow cytometry assay. The expression of proteins and phosphorylated kinases was detected using Western blotting.

Results: Treatment of U251 and U87 cells with anisomycin (0.01-8 μmol/L) inhibited the cell growth in time- and concentration-dependent manners (the IC(50) values at 48 h were 0.233±0.021 and 0.192±0.018 μmol/L, respectively). Anisomycin (4 μmol/L) caused 21.5%±2.2% and 25.3%±3.1% of apoptosis proportion, respectively, in U251 and U87 cells. In the two cell lines, anisomycin (4 μmol/L) activated p38 MAPK and JNK, and inactivated ERK1/2. However, neither the p38 MAPK inhibitor SB203580 (10 μmol/L) nor the JNK inhibitor SP600125 (10 μmol/L) prevented anisomycin-induced cell death. On the other hand, anisomycin (4 μmol/L) reduced the level of PP2A/C subunit (catalytic subunit) in a time-dependent manner in the two cell lines. Treatment of the two cell lines with the PP2A inhibitor okadaic acid (100 nmol/L) caused marked cell death.

Conclusion: Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit. The regulation of PP2A/C exression by anisomycin provides a clue to further study on its role in glioma therapy.

Citing Articles

Hesperetin but not ellagic acid increases myosin heavy chain expression and cell fusion in C2C12 myoblasts in the presence of oxidative stress.

Cuijpers I, Dohmen C, Bouwman F, Troost F, Sthijns M Front Nutr. 2024; 11:1377071.

PMID: 39285862 PMC: 11402829. DOI: 10.3389/fnut.2024.1377071.

Comprehensive investigation of the prognostic values and molecular mechanisms of syntaxin binding protein 5 antisense RNA 1 in patients with colon adenocarcinoma based on RNA sequencing dataset.

Wei H, Tang L, Wang J, Ni M, Liao X, Guo E J Cancer. 2023; 14(9):1607-1622.

PMID: 37325053 PMC: 10266242. DOI: 10.7150/jca.83423.

Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways.

Xiong Y, Liu T, Chen J J Cancer. 2023; 14(7):1202-1215.

PMID: 37215446 PMC: 10197939. DOI: 10.7150/jca.83355.

Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1/lipoic acid pathway activation.

Nie X, Chen H, Xiong Y, Chen J, Liu T J Cancer. 2022; 13(14):3503-3514.

PMID: 36484005 PMC: 9723990. DOI: 10.7150/jca.77445.

Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma Wildtype.

Kashani E, Vassella E Cancers (Basel). 2022; 14(21).

PMID: 36358647 PMC: 9654311. DOI: 10.3390/cancers14215227.

References

Gotz J, Probst A, Ehler E, Hemmings B, Kues W . Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci U S A. 1998; 95(21):12370-5. PMC: 22838. DOI: 10.1073/pnas.95.21.12370. View

Ashley D, Riffkin C, Muscat A, Knight M, Kaye A, Novak U . Caspase 8 is absent or low in many ex vivo gliomas. Cancer. 2005; 104(7):1487-96. DOI: 10.1002/cncr.21323. View

Gold P . Protein synthesis inhibition and memory: formation vs amnesia. Neurobiol Learn Mem. 2007; 89(3):201-11. PMC: 2346577. DOI: 10.1016/j.nlm.2007.10.006. View

Sadowski R, Canal C, Gold P . Lidocaine attenuates anisomycin-induced amnesia and release of norepinephrine in the amygdala. Neurobiol Learn Mem. 2011; 96(2):136-42. PMC: 3148321. DOI: 10.1016/j.nlm.2011.03.007. View

Lunghi P, Tabilio A, Pinelli S, Valmadre G, Ridolo E, Albertini R . Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. Hematol J. 2001; 2(2):70-80. DOI: 10.1038/sj/thj/6200095. View

Rosen K, Shi W, Calabretta B, Filmus J . Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J Biol Chem. 2002; 277(48):46123-30. DOI: 10.1074/jbc.M207883200. View

Qiao S, Murakami K, Zhao Q, Wang B, Seo H, Yamashita H . Mimosine-induced apoptosis in C6 glioma cells requires the release of mitochondria-derived reactive oxygen species and p38, JNK activation. Neurochem Res. 2011; 37(2):417-27. DOI: 10.1007/s11064-011-0628-6. View

Wong L, Zhang D, Chang C, Koay E . Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis. Exp Cell Res. 2010; 316(20):3387-96. DOI: 10.1016/j.yexcr.2010.06.007. View

Croons V, Martinet W, Herman A, Timmermans J, De Meyer G . The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase. J Pharmacol Exp Ther. 2009; 329(3):856-64. DOI: 10.1124/jpet.108.149948. View

10.

Mawji I, Simpson C, Hurren R, Gronda M, Williams M, Filmus J . Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst. 2007; 99(10):811-22. DOI: 10.1093/jnci/djk182. View

11.

Li X, Scuderi A, Letsou A, Virshup D . B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol Cell Biol. 2002; 22(11):3674-84. PMC: 133809. DOI: 10.1128/MCB.22.11.3674-3684.2002. View

12.

Xia Z, Dickens M, Raingeaud J, Davis R, Greenberg M . Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995; 270(5240):1326-31. DOI: 10.1126/science.270.5240.1326. View

13.

Wang Q, Zhang J, Liu S, Li H . Overactivated mitogen-activated protein kinase by anisomycin induces tau hyperphosphorylation. Sheng Li Xue Bao. 2008; 60(4):485-91. View

14.

Mawji I, Simpson C, Gronda M, Williams M, Hurren R, Henderson C . A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis. Cancer Res. 2007; 67(17):8307-15. DOI: 10.1158/0008-5472.CAN-07-1687. View

15.

Frisch S, Screaton R . Anoikis mechanisms. Curr Opin Cell Biol. 2001; 13(5):555-62. DOI: 10.1016/s0955-0674(00)00251-9. View

16.

Malysheva M, Grigoryev A, Bulycheva T, Zatsepina O . Enhanced sensitivity of nucleoli in human proliferating cells to inhibition of protein synthesis with anisomycin. Bull Exp Biol Med. 2011; 150(2):258-62. DOI: 10.1007/s10517-010-1118-6. View

17.

Piekarski D, Seto T, Zucker I . The protein synthesis inhibitor anisomycin reduces sex behavior during a critical period after testosterone treatment in male Syrian hamsters. Physiol Behav. 2011; 105(2):215-9. DOI: 10.1016/j.physbeh.2011.08.025. View

18.

He X, Anderson J, Del Pozo O, Gu Y, Tang X, Martin G . Silencing of subfamily I of protein phosphatase 2A catalytic subunits results in activation of plant defense responses and localized cell death. Plant J. 2004; 38(4):563-77. DOI: 10.1111/j.1365-313X.2004.02073.x. View

19.

Junttila M, Li S, Westermarck J . Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 2007; 22(4):954-65. DOI: 10.1096/fj.06-7859rev. View

20.

Frisch S, Francis H . Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994; 124(4):619-26. PMC: 2119917. DOI: 10.1083/jcb.124.4.619. View